
Drugging the Undruggable®
Location: Cambridge, UK
Mission: Discover druggable targets across the human proteome using SITESEEKER and PROTEINi
Employees: 30
Total funding: USD 76,100,000
Target discovery and early-stage drug discovery focused on identifying previously intractable drug targets across the human proteome.
Biotechnology / Drug discovery
USD 15,000,000
Reported as $15M (≈£11M) Series A
USD 46,000,000
Reported as £33M (≈$46M) Series B led by BGF
USD 12,000,000
Series B extension reported on Sep 12, 2024
“Parkwalk Advisors; BGF; Jonathan Milner; Amadeus Capital Partners; Cambridge Enterprise; Morningside Ventures; Astellas Venture Management”